SciELO - Scientific Electronic Library Online

 
vol.80 issue2Potential plant poisonings in dogs and cats in Southern AfricaEffects of lumbosacral epidural ketamine and lidocaine in xylazine-sedated cats author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Journal of the South African Veterinary Association

On-line version ISSN 2224-9435
Print version ISSN 1019-9128

J. S. Afr. Vet. Assoc. vol.80 n.2 Cape Town  2009

 

REVIEW ARTICLE OORSIGARTIKEL

 

Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: A review

 

 

T P M SchettersI, II; K MoubriII; B M CookeIII

IMicrobiology R&D Department, Intervet/Schering-Plough Animal Health, Boxmeer, the Netherlands
IILaboratoire de Biologie Cellulaire et Moléculaire, University of Montpellier I, Montpellier, France
IIIDepartment of Microbiology, Monash University, Victoria, Australia

 

 


ABSTRACT

Babesia canis and B. rossi are large Babesia species that infect dogs and cause clinical disease. The spectrum of disease is highly diverse with either parasite, but upon evaluation of field cases it has been suggested that in general B. rossi is more virulent than B. canis. This difference was also found in experimental infections using B. canis and B. rossi isolates and appeared to be related to a difference in parasitaemia. Whether this difference reflects the essential difference between B. canis and B. rossi species in general, or merely reflects the variability in virulence of individual isolates cannot be discerned. Comparative in vitro and in vivo studies revealed a number of qualitative differences between the B. canis and B. rossi isolates studied; however, more research is required to determine any causal relationship between in vitro and in vivo characteristics. Vaccination with a bivalent vaccine (containing soluble parasite antigen [SPA] from supernatants of in vitro cultures of B. canis and B. rossi) induced protection against clinical babesiosis upon challenge infection with either parasite. The dynamics of parasitaemia upon challenge infection of vaccinated animals indicated a biological difference between the B. canis and B. rossi isolates studied. Vaccinated dogs that were challenged with B. rossi parasites (2 isolates tested) effectively controlled parasitaemia. By contrast, in vaccinated dogs that were challenged with B. canis isolates (2 isolates tested) there was little or no effect on parasitaemia but levels of SPA in plasma were reduced. Apparently the nature of vaccine-induced immunity differs with respect to the challenge species.

Keywords: Babesia canis, Babesia rossi, immunity, pathogenesis, vaccine


 

 

“Full text available only in PDF format”

 

 

REFERENCES

1. Allred D R, Hines S A, Ahrens K P 1993 Isolate specific parasite antigens of the Babesia bovis-infected erythrocyte surface. Molecular and Biochemical Parasitology 60: 121-132        [ Links ]

2. Allred D R, Al-Khedery B 2004 Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Molecular and Biochemical Parasitology 134: 27-35        [ Links ]

3. Bourdoiseau G 2006 Canine babesiosis in France. Veterinary Parasitology 138: 118-125        [ Links ]

4. Cacciö S M, Antunovic B, Moretti A, Mangili V, Marinculic A, Baric R R, Slemenda S B, Pieniazek N J 2002 Molecular characterisation of Babesia canis canis and Babesia canis vogeli from naturally infected European dogs. Veterinary Parasitology 106: 285-292        [ Links ]

5. Carret C, Walas F, Carcy B, Grande N, Précigout E, Moubri K, Schetters T P, Gorenflot A 1999 Babesia canis canis, Babesia canis vogeli, Babesia canis rossi: differentiation of the three subspecies by a restriction fragment length polymorphism analysis on amplified small subunit ribosomal RNA genes. Journal of Eukaryotic Microbiology 46: 298-303        [ Links ]

6. Depoix D, Carcy B, Jumas-Bilak E, Pages M, Précigout E, Schetters T P, Ravel C, Gorenflot A 2002 Chromosome number, genome size and polymorphism of European and South African isolates of large Babesia parasites that infect dogs. Parasitology 125: 313-321        [ Links ]

7. Furlanello T, Fiorio F, Caldin M, Lubas G, Solano-Gallego L 2005 Clinicopathological findings in naturally occurring cases of babesiosis caused by large form Babesia from dogs of northeastern Italy. Veterinary Parasitology 134: 77-85        [ Links ]

8. Hauschield S, Shayan P, Schein E 1995 Characterization and comparison of merozoite antigens of different Babesia canis isolates by serological and immunological investigations. Parasitology Research 81: 638-642        [ Links ]

9. Hutchings C L, Li A, Fernandez K M, Fletcher T, Jackson L A, Molloy J B, Jorgensen W K, Lim C T, Cooke B M 2007 New insights into the altered adhesive and mechanical properties of red blood cells parasitised by Babesia bovis. Molecular Microbiology 65: 1092-1105        [ Links ]

10. Igarashi I, Aikawa M, Kreier J P 1988 Host cell-parasite interactions in babesiosis. In Ristic M (ed.) Babesiosis of domestic animals and man. CRC Press, Boca Raton: 53-69        [ Links ]

11. Jacobson L J 2006 The South African form of severe and complicated canine babesiosis: clinical advances 1994-2004. Veterinary Parasitology 138: 126-139        [ Links ]

12. Kuttler K L 1988 World-wide impact of babesiosis. In Ristic M (ed.) Babesiosis of domestic animals and man CRC Press, Boca Raton: 1-22        [ Links ]

13. Lewis B D, Penzhorn B L, Lopez-Rebollar L M 1995 Immune responses to South African Babesia canis and the development of a preliminary vaccine. Journal of the South African Veterinary Association 66: 61-65        [ Links ]

14. Malherbe W D 1956 The manifestations and diagnosis of Babesia infections. Annals of the New York Academy of Sciences 64: 128-146        [ Links ]

15. Martinod S, Laurent N, Moreau Y 1986 Resistance and immunity of dogs against Babesia canis in an endemic area. Veterinary Parasitology 19: 245-254        [ Links ]

16. Matijatko V, Mrljak V, Kissl, Kucer N, Forsek J, Zmvicnjak T, Romic Z, Simec Z, Ceron J J 2007 Evidence of an acute phase response in dogs naturally infected with Babesia canis. Veterinary Parasitology 144: 242-250        [ Links ]

17. Molinar E, James M A, Kakoma I, Holland C, Ristic M 1983 Antigenic and immunogenic studies on cell culture-derived Babesia canis. Veterinary Parasitology 10: 29-40        [ Links ]

18. Moreau Y, Martinod S, Fayet G 1988 Epidemiologic and immunoprophylactic aspects of canine babesiosis in France. In Ristic M (ed.) Babesiosis of domestic animals and man. CRC Press, Boca Raton:191-196        [ Links ]

19. Nuttal G H F 1904 Canine piroplasmosis I. Journal of Hygiene 4: 219-252        [ Links ]

20. Reyers F, Leisewitz A L, Lobetti R G, Milner R J, Jacobson L J 1988 Canine babesiosis in South Africa: more than one disease. Does this serve as a model for falciparum malaria? Annals of Tropical Medicine and Parasitology 92: 503-511        [ Links ]

21. Ristic M, Kakoma I 1988 Exoantigens of Babesia. In Ristic M (ed.) Babesiosis of domestic animals and man. CRC Press, Boca Raton: 131-141        [ Links ]

22. Schetters Th P M, Montenegro-James S 1995 Vaccines against babesiosis using soluble parasite antigens. Parasitology Today 11: 456-462        [ Links ]

23. Schetters Th P M, Scholtes N C, Kleuskens J A G M, Bos H J 1996 Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis. Parasite Immunology 18: 1-6        [ Links ]

24. Schetters Th, Kleuskens J, Scholtes N, Moubri K, Gorenflot A 1997 Different Babesia canis isolates, different diseases. Parasitology 115: 485-493        [ Links ]

25. Schetters T P M, Kleuskens J, Scholtes N, Gorenflot A 1998 Parasite localisation and dissemination in the Babesia-infected host. Annals of Tropical Medicine and Parasitology 92: 513-519        [ Links ]

26. Schetters Th P M, Eling W M C 1999 Can Babesia infections be used as a model for cerebral malaria? Parasitology Today 15: 492-497        [ Links ]

27. Schetters Th P M, Kleuskens J A G M, Scholtes N C, Gorenflot A, Moubry K, Vermeulen A N 2001 Vaccination of dogs against heterologous Babesia canis infection using antigens from in vitro culture supernatants. Veterinary Parasitology 100: 75-86        [ Links ]

28. Schetters Th P M, Kleuskens J A G M, Scholtes N C, Van De Crommert J, Krijnen E, Moubri K, Gorenflot A, Vermeulen A N 2006 Onset and duration of immunity against B. canis infection in dogs vaccinated with antigens from culture supernatants. Veterinary Parasitology 138: 140-146        [ Links ]

29. Schetters Th P M, Strydom T, Crafford D, Kleuskens J, Van de Crommert J, Vermeulen A N 2007 Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants. Veterinary Parasitology 144: 10-19        [ Links ]

30. Schetters Th P M, Kleuskens J, Carcy B, Gorenflot A, Vermeulen A 2007 Vaccination against large Babesia species from dogs. Parassitologia 49, Suppl. 1: 13-17        [ Links ]

31. Sibinovic K H, Sibinovic S, Ristic M, Cox H G 1967 Immunogenic properties of babesial serum antigens. Journal of Parasitology 53: 1121-1129        [ Links ]

32. Uilenberg G, Franssen F F J, Perié N M, Spanjer A A M 1989 Three groups of Babesia canis distinguished and a proposal for nomenclature. Veterinary Quarterly 11: 33-40        [ Links ]

33. Uilenberg G 2006 Babesia- A historical overview. Veterinary Parasitology 138: 3-10        [ Links ]

34. Wright I G, Goodger B V 1988 Pathogenesis of babesiosis. In Ristic M (ed.) Babesiosis of domestic animals and man, CRC Press, Boca Raton: 99-118        [ Links ]

35. Zahler M, Schein E, Rinder H, Gothe R 1998 Characteristic genotypes discriminate between Babesia canis isolates of differing vector specificity and pathogenicity to dogs. Parasitology Research 84: 544-548        [ Links ]

 

 

Received: July 2008
Accepted: March 2009

 

 

* Author for correspondence. E-mail: theo.schetters@sp.intervet.com

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License